Osaic Holdings
DERM icon

Osaic Holdings’s Journey Medical DERM Stock Holding History

Osaic Holdings’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.7K Buy
9,002
+355
+4% +$2.03K ﹤0.01% 5303
2026
Q1 		$40.6K Sell
8,647
-400
-4% -$3.1K ﹤0.01% 5367
2025
Q4 		$69.7K Sell
9,047
-3,135
-26% -$24.6K ﹤0.01% 5002
2025
Q3 		$87.7K Sell
12,182
-1,419
-10% -$10.3K ﹤0.01% 4899
2025
Q2 		$97.6K Sell
13,601
-1,011
-7% -$6.99K ﹤0.01% 4522
2025
Q1 		$86.2K Buy
14,612
+2,596
+22% +$12.8K ﹤0.01% 4284
2024
Q4 		$47K Buy
12,016
+9,037
+303% +$49.4K ﹤0.01% 4756
2024
Q3 		$16.8K Buy
2,979
+2,579
+645% +$13.3K ﹤0.01% 5483
2024
Q2 		$2.26K Buy
+400
New +$1.65K ﹤0.01% 6550
2024
Q1 		– Sell
-5,455
Closed -$31.4K – 7234
2023
Q4 		$31.4K Buy
+5,455
New +$24.3K ﹤0.01% 5211

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Osaic Holdings's DERM Position: Q2 2026 in Review

Osaic Holdings increased its Journey Medical (DERM) stake by 4.1% in Q2 2026, buying an estimated $2.03K and bringing the position to 9,002 shares worth $63.7K. The position accounts for ﹤0.01% of the portfolio, ranked #5303.

Osaic Holdings first reported a position in DERM in Q4 2023 and has held it in 10 quarters since. The position peaked at $97.6K in Q2 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • Osaic Holdings held 9,002 shares of Journey Medical worth $63.7K as of Q2 2026.
  • Osaic Holdings bought 355 Journey Medical shares in Q2 2026, an estimated $2.03K.
  • Journey Medical made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5303 holding.
  • Osaic Holdings first reported a position in Journey Medical in Q4 2023 and has held it in 10 quarters since.
  • Osaic Holdings's Journey Medical position peaked at $97.6K in Q2 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.